Suppr超能文献

30 位健康受试者 21 项血液学参数的个体内和个体间生物学变异估计值。

Within-subject and between-subject biological variation estimates of 21 hematological parameters in 30 healthy subjects.

机构信息

Department of Medical Biochemistry, Acibadem Mehmet Ali Aydınlar University, School of Medicine, Atasehir, Istanbul, Turkey.

Servizio Medicina di Laboratorio, Ospedale San Raffaele, Milan, Italy.

出版信息

Clin Chem Lab Med. 2018 Jul 26;56(8):1309-1318. doi: 10.1515/cclm-2017-1155.

Abstract

BACKGROUND

The complete blood count (CBC) is used to evaluate health status in the contexts of various clinical situations such as anemia, infection, inflammation, trauma, malignancies, etc. To ensure safe clinical application of the CBC, reliable biological variation (BV) data are required. The study aim was to define the BVs of CBC parameters employing a strict protocol.

METHODS

Blood samples, drawn from 30 healthy subjects (17 females, 13 males) once weekly for 10 weeks, were analyzed using a Sysmex XN 3000 instrument. The data were assessed for normality, trends, outliers and variance homogeneity prior to coefficient of variation (CV)-analysis of variance (ANOVA). Sex-stratified within-subject (CVI) and between-subjects (CVG) BV estimates were determined for 21 CBC parameters.

RESULTS

For leukocyte parameters, with the exception of lymphocytes and basophils, significant differences were found between female/male CVI estimates. The mean values of all erythrocyte-, reticulocyte- and platelet parameters differed significantly between the sexes, except for mean corpuscular hemoglobin concentration, mean corpuscular volume and platelet numbers. Most CVI and CVG estimates appear to be lower than those previously published.

CONCLUSIONS

Our study, based on a rigorous protocol, provides updated and more stringent BV estimates for CBC parameters. Sex stratification of data is necessary when exploring the significance of changes in consecutive results and when setting analytical performance specifications.

摘要

背景

全血细胞计数(CBC)用于评估各种临床情况下的健康状况,如贫血、感染、炎症、创伤、恶性肿瘤等。为了确保 CBC 的安全临床应用,需要可靠的生物学变异(BV)数据。本研究旨在采用严格的方案来确定 CBC 参数的 BVs。

方法

从 30 名健康受试者(17 名女性,13 名男性)中抽取血液样本,每周一次,连续 10 周,使用 Sysmex XN 3000 仪器进行分析。在进行变异系数(CV)-方差分析(ANOVA)分析之前,对数据进行正态性、趋势、离群值和方差同质性评估。为 21 个 CBC 参数确定了性别分层的个体内(CVI)和个体间(CVG)BV 估计值。

结果

除淋巴细胞和嗜碱性粒细胞外,白细胞参数的女性/男性 CVI 估计值存在显著差异。除平均红细胞血红蛋白浓度、平均红细胞体积和血小板数外,所有红细胞、网织红细胞和血小板参数的平均值在性别之间存在显著差异。大多数 CVI 和 CVG 估计值似乎低于先前发表的值。

结论

本研究基于严格的方案,为 CBC 参数提供了更新和更严格的 BV 估计值。在探索连续结果变化的意义和设置分析性能规格时,需要对数据进行性别分层。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验